Quantifying the Determinants of Evolutionary Dynamics Leading to Drug Resistance

Guillaume Chevereau, Marta Dravecká, Tugce Batur, Aysegul Guvenek, Dilay Hazal Ayhan, Erdal Toprak, Tobias Bollenbach

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

The emergence of drug resistant pathogens is a serious public health problem. It is a long-standing goal to predict rates of resistance evolution and design optimal treatment strategies accordingly. To this end, it is crucial to reveal the underlying causes of drug-specific differences in the evolutionary dynamics leading to resistance. However, it remains largely unknown why the rates of resistance evolution via spontaneous mutations and the diversity of mutational paths vary substantially between drugs. Here we comprehensively quantify the distribution of fitness effects (DFE) of mutations, a key determinant of evolutionary dynamics, in the presence of eight antibiotics representing the main modes of action. Using precise high-throughput fitness measurements for genome-wide Escherichia coli gene deletion strains, we find that the width of the DFE varies dramatically between antibiotics and, contrary to conventional wisdom, for some drugs the DFE width is lower than in the absence of stress. We show that this previously underappreciated divergence in DFE width among antibiotics is largely caused by their distinct drug-specific dose-response characteristics. Unlike the DFE, the magnitude of the changes in tolerated drug concentration resulting from genome-wide mutations is similar for most drugs but exceptionally small for the antibiotic nitrofurantoin, i.e., mutations generally have considerably smaller resistance effects for nitrofurantoin than for other drugs. A population genetics model predicts that resistance evolution for drugs with this property is severely limited and confined to reproducible mutational paths. We tested this prediction in laboratory evolution experiments using the “morbidostat”, a device for evolving bacteria in well-controlled drug environments. Nitrofurantoin resistance indeed evolved extremely slowly via reproducible mutations—an almost paradoxical behavior since this drug causes DNA damage and increases the mutation rate. Overall, we identified novel quantitative characteristics of the evolutionary landscape that provide the conceptual foundation for predicting the dynamics of drug resistance evolution.

Original languageEnglish (US)
Article numbere1002299
JournalPLoS Biology
Volume13
Issue number11
DOIs
StatePublished - Nov 18 2015

Fingerprint

drug resistance
Drug Resistance
drugs
Pharmaceutical Preparations
Nitrofurantoin
mutation
Anti-Bacterial Agents
antibiotics
Mutation
Genes
Genome
Controlled Environment
Genetic Models
Gene Deletion
Population Genetics
genome
Mutation Rate
gene deletion
DNA Damage
Public health

ASJC Scopus subject areas

  • Agricultural and Biological Sciences(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Immunology and Microbiology(all)
  • Neuroscience(all)

Cite this

Chevereau, G., Dravecká, M., Batur, T., Guvenek, A., Ayhan, D. H., Toprak, E., & Bollenbach, T. (2015). Quantifying the Determinants of Evolutionary Dynamics Leading to Drug Resistance. PLoS Biology, 13(11), [e1002299]. https://doi.org/10.1371/journal.pbio.1002299

Quantifying the Determinants of Evolutionary Dynamics Leading to Drug Resistance. / Chevereau, Guillaume; Dravecká, Marta; Batur, Tugce; Guvenek, Aysegul; Ayhan, Dilay Hazal; Toprak, Erdal; Bollenbach, Tobias.

In: PLoS Biology, Vol. 13, No. 11, e1002299, 18.11.2015.

Research output: Contribution to journalArticle

Chevereau, G, Dravecká, M, Batur, T, Guvenek, A, Ayhan, DH, Toprak, E & Bollenbach, T 2015, 'Quantifying the Determinants of Evolutionary Dynamics Leading to Drug Resistance', PLoS Biology, vol. 13, no. 11, e1002299. https://doi.org/10.1371/journal.pbio.1002299
Chevereau, Guillaume ; Dravecká, Marta ; Batur, Tugce ; Guvenek, Aysegul ; Ayhan, Dilay Hazal ; Toprak, Erdal ; Bollenbach, Tobias. / Quantifying the Determinants of Evolutionary Dynamics Leading to Drug Resistance. In: PLoS Biology. 2015 ; Vol. 13, No. 11.
@article{5d995da20f6c4b1e9dfce88a9c3dfa90,
title = "Quantifying the Determinants of Evolutionary Dynamics Leading to Drug Resistance",
abstract = "The emergence of drug resistant pathogens is a serious public health problem. It is a long-standing goal to predict rates of resistance evolution and design optimal treatment strategies accordingly. To this end, it is crucial to reveal the underlying causes of drug-specific differences in the evolutionary dynamics leading to resistance. However, it remains largely unknown why the rates of resistance evolution via spontaneous mutations and the diversity of mutational paths vary substantially between drugs. Here we comprehensively quantify the distribution of fitness effects (DFE) of mutations, a key determinant of evolutionary dynamics, in the presence of eight antibiotics representing the main modes of action. Using precise high-throughput fitness measurements for genome-wide Escherichia coli gene deletion strains, we find that the width of the DFE varies dramatically between antibiotics and, contrary to conventional wisdom, for some drugs the DFE width is lower than in the absence of stress. We show that this previously underappreciated divergence in DFE width among antibiotics is largely caused by their distinct drug-specific dose-response characteristics. Unlike the DFE, the magnitude of the changes in tolerated drug concentration resulting from genome-wide mutations is similar for most drugs but exceptionally small for the antibiotic nitrofurantoin, i.e., mutations generally have considerably smaller resistance effects for nitrofurantoin than for other drugs. A population genetics model predicts that resistance evolution for drugs with this property is severely limited and confined to reproducible mutational paths. We tested this prediction in laboratory evolution experiments using the “morbidostat”, a device for evolving bacteria in well-controlled drug environments. Nitrofurantoin resistance indeed evolved extremely slowly via reproducible mutations—an almost paradoxical behavior since this drug causes DNA damage and increases the mutation rate. Overall, we identified novel quantitative characteristics of the evolutionary landscape that provide the conceptual foundation for predicting the dynamics of drug resistance evolution.",
author = "Guillaume Chevereau and Marta Draveck{\'a} and Tugce Batur and Aysegul Guvenek and Ayhan, {Dilay Hazal} and Erdal Toprak and Tobias Bollenbach",
year = "2015",
month = "11",
day = "18",
doi = "10.1371/journal.pbio.1002299",
language = "English (US)",
volume = "13",
journal = "PLoS Biology",
issn = "1544-9173",
publisher = "Public Library of Science",
number = "11",

}

TY - JOUR

T1 - Quantifying the Determinants of Evolutionary Dynamics Leading to Drug Resistance

AU - Chevereau, Guillaume

AU - Dravecká, Marta

AU - Batur, Tugce

AU - Guvenek, Aysegul

AU - Ayhan, Dilay Hazal

AU - Toprak, Erdal

AU - Bollenbach, Tobias

PY - 2015/11/18

Y1 - 2015/11/18

N2 - The emergence of drug resistant pathogens is a serious public health problem. It is a long-standing goal to predict rates of resistance evolution and design optimal treatment strategies accordingly. To this end, it is crucial to reveal the underlying causes of drug-specific differences in the evolutionary dynamics leading to resistance. However, it remains largely unknown why the rates of resistance evolution via spontaneous mutations and the diversity of mutational paths vary substantially between drugs. Here we comprehensively quantify the distribution of fitness effects (DFE) of mutations, a key determinant of evolutionary dynamics, in the presence of eight antibiotics representing the main modes of action. Using precise high-throughput fitness measurements for genome-wide Escherichia coli gene deletion strains, we find that the width of the DFE varies dramatically between antibiotics and, contrary to conventional wisdom, for some drugs the DFE width is lower than in the absence of stress. We show that this previously underappreciated divergence in DFE width among antibiotics is largely caused by their distinct drug-specific dose-response characteristics. Unlike the DFE, the magnitude of the changes in tolerated drug concentration resulting from genome-wide mutations is similar for most drugs but exceptionally small for the antibiotic nitrofurantoin, i.e., mutations generally have considerably smaller resistance effects for nitrofurantoin than for other drugs. A population genetics model predicts that resistance evolution for drugs with this property is severely limited and confined to reproducible mutational paths. We tested this prediction in laboratory evolution experiments using the “morbidostat”, a device for evolving bacteria in well-controlled drug environments. Nitrofurantoin resistance indeed evolved extremely slowly via reproducible mutations—an almost paradoxical behavior since this drug causes DNA damage and increases the mutation rate. Overall, we identified novel quantitative characteristics of the evolutionary landscape that provide the conceptual foundation for predicting the dynamics of drug resistance evolution.

AB - The emergence of drug resistant pathogens is a serious public health problem. It is a long-standing goal to predict rates of resistance evolution and design optimal treatment strategies accordingly. To this end, it is crucial to reveal the underlying causes of drug-specific differences in the evolutionary dynamics leading to resistance. However, it remains largely unknown why the rates of resistance evolution via spontaneous mutations and the diversity of mutational paths vary substantially between drugs. Here we comprehensively quantify the distribution of fitness effects (DFE) of mutations, a key determinant of evolutionary dynamics, in the presence of eight antibiotics representing the main modes of action. Using precise high-throughput fitness measurements for genome-wide Escherichia coli gene deletion strains, we find that the width of the DFE varies dramatically between antibiotics and, contrary to conventional wisdom, for some drugs the DFE width is lower than in the absence of stress. We show that this previously underappreciated divergence in DFE width among antibiotics is largely caused by their distinct drug-specific dose-response characteristics. Unlike the DFE, the magnitude of the changes in tolerated drug concentration resulting from genome-wide mutations is similar for most drugs but exceptionally small for the antibiotic nitrofurantoin, i.e., mutations generally have considerably smaller resistance effects for nitrofurantoin than for other drugs. A population genetics model predicts that resistance evolution for drugs with this property is severely limited and confined to reproducible mutational paths. We tested this prediction in laboratory evolution experiments using the “morbidostat”, a device for evolving bacteria in well-controlled drug environments. Nitrofurantoin resistance indeed evolved extremely slowly via reproducible mutations—an almost paradoxical behavior since this drug causes DNA damage and increases the mutation rate. Overall, we identified novel quantitative characteristics of the evolutionary landscape that provide the conceptual foundation for predicting the dynamics of drug resistance evolution.

UR - http://www.scopus.com/inward/record.url?scp=84949478882&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84949478882&partnerID=8YFLogxK

U2 - 10.1371/journal.pbio.1002299

DO - 10.1371/journal.pbio.1002299

M3 - Article

C2 - 26581035

AN - SCOPUS:84949478882

VL - 13

JO - PLoS Biology

JF - PLoS Biology

SN - 1544-9173

IS - 11

M1 - e1002299

ER -